XML 83 R67.htm IDEA: XBRL DOCUMENT v3.6.0.2
Subsidiary Guarantors for Credit Agreement, Term Loan and 2021 Notes Subsidiary Guarantors for Credit Agreement, Term Loan and 2021 Notes (Details) - USD ($)
$ in Thousands
3 Months Ended
Jan. 27, 2017
Jan. 29, 2016
Oct. 28, 2016
Oct. 30, 2015
Condensed Consolidating Statement of Income        
Net sales $ 497,769 $ 526,300    
Cost of sales 389,108 438,256    
Product development, selling and administrative expenses 111,111 110,413    
Restructuring expenses 772 26,659    
Other income (1,472) (3,941)    
Operating loss (1,750) (45,087)    
Intercompany items 0 0    
Interest (expense) income, net (11,022) (12,116)    
Loss before income taxes (12,772) (57,203)    
(Benefit) income for income taxes (12,495) (16,982)    
Equity in (loss) income of subsidiaries 0 0    
Net loss (277) (40,221)    
Comprehensive (loss) income (2,899) (72,584)    
Current assets:        
Cash and cash equivalents 321,909   $ 276,709  
Accounts receivable, net 639,881   683,958  
Inventories 836,465   814,821  
Other current assets 133,005   113,434  
Assets held for sale 330   3,703  
Total current assets 1,931,590   1,892,625  
Property, plant and equipment, net 642,882   656,245  
Other assets:        
Other intangible assets, net 217,081   223,411  
Goodwill 350,762   350,843  
Deferred income taxes 179,539   171,775  
Other non-current assets 123,650   128,401  
Total other assets 871,032   874,430  
Total assets 3,445,504   3,423,300  
Current liabilities:        
Short-term borrowings, including current portion of long-term obligations 43,006   41,611  
Trade accounts payable 219,502   236,787  
Employee compensation and benefits 72,532   91,224  
Advance payments and progress billings 242,450   173,121  
Accrued warranties 40,775 50,518 40,787 $ 52,146
Other accrued liabilities 167,657   188,591  
Total current liabilities 785,922   772,121  
Long-term obligations 953,241   962,291  
Other liabilities:        
Liabilities for postretirement benefits 14,249   14,260  
Accrued pension costs 169,471   175,120  
Other non-current liabilities 127,930   117,802  
Total other liabilities 311,650   307,182  
Shareholders’ equity 1,394,691   1,381,706  
Total liabilities and shareholders’ equity 3,445,504   3,423,300  
Operating Activities:        
Net cash provided (used) by operating activities 41,473 108,589    
Investing Activities:        
Property, plant and equipment acquired (6,611) (8,103)    
Proceeds from sale of property, plant and equipment 4,900 9,167    
Other investing activities, net 0 122    
Net cash (used) provided by investing activities (1,711) 1,186    
Financing Activities:        
Common stock issued 10,668 0    
Dividends paid (1,009) (997)    
Repayments of term loan (9,375) (4,687)    
Payments on credit agreement 0 (58,600)    
Financing fees 0 (1,011)    
Other financing activities, net 5,284 (1,507)    
Net cash provided (used) by financing activities 5,568 (66,802)    
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (60) (5,925)    
Increase in Cash, Cash Equivalents and Restricted Cash 45,270 37,048    
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 278,219 102,885    
Cash, Cash Equivalents and Restricted Cash at End of Period 323,489 139,933    
Credit Agreement, Term Loan, and Senior Notes due 2021 | Parent Company        
Current liabilities:        
Short-term borrowings, including current portion of long-term obligations     37,057  
Trade accounts payable     4,013  
Employee compensation and benefits     8,346  
Advance payments and progress billings     0  
Accrued warranties     0  
Other accrued liabilities     87,958  
Total current liabilities     137,374  
Long-term obligations     962,251  
Other liabilities:        
Liabilities for postretirement benefits     14,260  
Accrued pension costs     175,120  
Other non-current liabilities     (9,571)  
Total other liabilities     179,809  
Shareholders’ equity     1,381,706  
Total liabilities and shareholders’ equity     2,661,140  
Credit Agreement, Term Loan, and Senior Notes due 2021 | Subsidiary Guarantors        
Current liabilities:        
Short-term borrowings, including current portion of long-term obligations     0  
Trade accounts payable     80,848  
Employee compensation and benefits     28,363  
Advance payments and progress billings     69,174  
Accrued warranties     16,909  
Other accrued liabilities     38,376  
Total current liabilities     233,670  
Long-term obligations     0  
Other liabilities:        
Liabilities for postretirement benefits     0  
Accrued pension costs     0  
Other non-current liabilities     9,832  
Total other liabilities     9,832  
Shareholders’ equity     2,959,691  
Total liabilities and shareholders’ equity     3,203,193  
Credit Agreement, Term Loan, and Senior Notes due 2021 | Non-Guarantor Subsidiaries        
Current liabilities:        
Short-term borrowings, including current portion of long-term obligations     4,554  
Trade accounts payable     151,926  
Employee compensation and benefits     54,515  
Advance payments and progress billings     104,427  
Accrued warranties     23,878  
Other accrued liabilities     67,801  
Total current liabilities     407,101  
Long-term obligations     40  
Other liabilities:        
Liabilities for postretirement benefits     0  
Accrued pension costs     0  
Other non-current liabilities     117,541  
Total other liabilities     117,541  
Shareholders’ equity     4,258,026  
Total liabilities and shareholders’ equity     4,782,708  
Credit Agreement, Term Loan, and Senior Notes due 2021 | Reportable Legal Entities | Parent Company        
Condensed Consolidating Statement of Income        
Net sales 0 0    
Cost of sales 0 0    
Product development, selling and administrative expenses 12,089 7,380    
Restructuring expenses 0 395    
Other income 0 0    
Operating loss (12,089) (7,775)    
Intercompany items (14,809) 15,148    
Interest (expense) income, net 12,522 (12,720)    
Loss before income taxes (14,376) (5,347)    
(Benefit) income for income taxes (10,370) (11,505)    
Equity in (loss) income of subsidiaries 3,729 (46,379)    
Net loss (277) (40,221)    
Comprehensive (loss) income (2,899) (72,584)    
Current assets:        
Cash and cash equivalents 134,757   131,344  
Accounts receivable, net 0   3  
Inventories 0   0  
Other current assets 64,567   5,975  
Assets held for sale 0   0  
Total current assets 199,324   137,322  
Property, plant and equipment, net 17,904   18,521  
Other assets:        
Other intangible assets, net 0   0  
Goodwill 0   0  
Deferred income taxes 123,068   154,267  
Other non-current assets 2,321,894   2,351,030  
Total other assets 2,444,962   2,505,297  
Total assets 2,662,190   2,661,140  
Current liabilities:        
Short-term borrowings, including current portion of long-term obligations 37,057      
Trade accounts payable 2,157      
Employee compensation and benefits 10,311      
Advance payments and progress billings 0      
Accrued warranties 0      
Other accrued liabilities 93,581      
Total current liabilities 143,106      
Long-term obligations 953,194      
Other liabilities:        
Liabilities for postretirement benefits 14,249      
Accrued pension costs 169,471      
Other non-current liabilities (10,821)      
Total other liabilities 172,899      
Shareholders’ equity 1,392,991      
Total liabilities and shareholders’ equity 2,662,190      
Operating Activities:        
Net cash provided (used) by operating activities (1,267) 86,203    
Investing Activities:        
Property, plant and equipment acquired (99) (240)    
Proceeds from sale of property, plant and equipment 0 0    
Other investing activities, net   (7)    
Net cash (used) provided by investing activities (99) (247)    
Financing Activities:        
Common stock issued 10,668      
Dividends paid (1,009) (997)    
Repayments of term loan (9,375) (4,687)    
Payments on credit agreement   (58,600)    
Financing fees   (1,011)    
Other financing activities, net 3,740 0    
Net cash provided (used) by financing activities 4,024 (65,295)    
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash 0 0    
Increase in Cash, Cash Equivalents and Restricted Cash 2,658 20,661    
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 132,099 581    
Cash, Cash Equivalents and Restricted Cash at End of Period 134,757 21,242    
Credit Agreement, Term Loan, and Senior Notes due 2021 | Reportable Legal Entities | Subsidiary Guarantors        
Condensed Consolidating Statement of Income        
Net sales 258,298 263,598    
Cost of sales 201,114 233,004    
Product development, selling and administrative expenses 46,544 40,679    
Restructuring expenses 357 20,016    
Other income 620 (694)    
Operating loss 9,663 (29,407)    
Intercompany items (29,565) (47,734)    
Interest (expense) income, net 707 235    
Loss before income taxes (19,195) (76,906)    
(Benefit) income for income taxes 3,642 412    
Equity in (loss) income of subsidiaries 10,859 17,897    
Net loss (11,978) (59,421)    
Comprehensive (loss) income (12,421) (60,701)    
Current assets:        
Cash and cash equivalents 63,715   21,476  
Accounts receivable, net 174,912   186,332  
Inventories 381,306   377,875  
Other current assets 6,203   5,996  
Assets held for sale 330   3,703  
Total current assets 626,466   595,382  
Property, plant and equipment, net 207,293   214,488  
Other assets:        
Other intangible assets, net 176,195   187,018  
Goodwill 341,984   341,984  
Deferred income taxes 0   0  
Other non-current assets 2,374,734   1,864,321  
Total other assets 2,892,913   2,393,323  
Total assets 3,726,672   3,203,193  
Current liabilities:        
Short-term borrowings, including current portion of long-term obligations 0      
Trade accounts payable 88,399      
Employee compensation and benefits 17,361      
Advance payments and progress billings 120,733      
Accrued warranties 17,239      
Other accrued liabilities 35,139      
Total current liabilities 278,871      
Long-term obligations 0      
Other liabilities:        
Liabilities for postretirement benefits 0      
Accrued pension costs 0      
Other non-current liabilities 9,537      
Total other liabilities 9,537      
Shareholders’ equity 3,438,264      
Total liabilities and shareholders’ equity 3,726,672      
Operating Activities:        
Net cash provided (used) by operating activities (15,033) (4,944)    
Investing Activities:        
Property, plant and equipment acquired (1,273) (1,666)    
Proceeds from sale of property, plant and equipment 642 6,789    
Other investing activities, net   0    
Net cash (used) provided by investing activities (631) 5,123    
Financing Activities:        
Common stock issued 0      
Dividends paid 0 0    
Repayments of term loan 0 0    
Payments on credit agreement   0    
Financing fees   0    
Other financing activities, net 13 0    
Net cash provided (used) by financing activities 13 0    
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash 0 0    
Increase in Cash, Cash Equivalents and Restricted Cash (15,651) 179    
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 79,367 2,008    
Cash, Cash Equivalents and Restricted Cash at End of Period 63,716 2,187    
Credit Agreement, Term Loan, and Senior Notes due 2021 | Reportable Legal Entities | Non-Guarantor Subsidiaries        
Condensed Consolidating Statement of Income        
Net sales 388,369 390,749    
Cost of sales 303,944 309,335    
Product development, selling and administrative expenses 52,478 62,354    
Restructuring expenses 415 6,248    
Other income (2,092) (3,247)    
Operating loss 33,624 16,059    
Intercompany items 4,692 (6,071)    
Interest (expense) income, net (24,251) 369    
Loss before income taxes 14,065 10,357    
(Benefit) income for income taxes (5,767) (5,889)    
Equity in (loss) income of subsidiaries 0 0    
Net loss 19,832 16,246    
Comprehensive (loss) income 15,168 (15,030)    
Current assets:        
Cash and cash equivalents 123,437   123,889  
Accounts receivable, net 473,377   515,418  
Inventories 522,410   502,162  
Other current assets 62,235   101,463  
Assets held for sale 0   0  
Total current assets 1,181,459   1,242,932  
Property, plant and equipment, net 421,979   427,645  
Other assets:        
Other intangible assets, net 40,886   36,393  
Goodwill 8,778   8,859  
Deferred income taxes 56,471   17,508  
Other non-current assets 4,276,573   3,049,371  
Total other assets 4,382,708   3,112,131  
Total assets 5,986,146   4,782,708  
Current liabilities:        
Short-term borrowings, including current portion of long-term obligations 5,949      
Trade accounts payable 128,946      
Employee compensation and benefits 44,860      
Advance payments and progress billings 133,984      
Accrued warranties 23,536      
Other accrued liabilities 44,513      
Total current liabilities 381,788      
Long-term obligations 47      
Other liabilities:        
Liabilities for postretirement benefits 0      
Accrued pension costs 0      
Other non-current liabilities 129,214      
Total other liabilities 129,214      
Shareholders’ equity 5,475,097      
Total liabilities and shareholders’ equity 5,986,146      
Operating Activities:        
Net cash provided (used) by operating activities 57,773 27,330    
Investing Activities:        
Property, plant and equipment acquired (5,239) (6,197)    
Proceeds from sale of property, plant and equipment 4,258 2,378    
Other investing activities, net   129    
Net cash (used) provided by investing activities (981) (3,690)    
Financing Activities:        
Common stock issued 0      
Dividends paid 0 0    
Repayments of term loan 0 0    
Payments on credit agreement   0    
Financing fees   0    
Other financing activities, net 1,531 (1,507)    
Net cash provided (used) by financing activities 1,531 (1,507)    
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (60) (5,925)    
Increase in Cash, Cash Equivalents and Restricted Cash 58,263 16,208    
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 66,753 100,296    
Cash, Cash Equivalents and Restricted Cash at End of Period 125,016 116,504    
Credit Agreement, Term Loan, and Senior Notes due 2021 | Eliminations        
Condensed Consolidating Statement of Income        
Net sales (148,898) (128,047)    
Cost of sales (115,950) (104,083)    
Product development, selling and administrative expenses 0 0    
Restructuring expenses 0 0    
Other income 0 0    
Operating loss (32,948) (23,964)    
Intercompany items 39,682 38,657    
Interest (expense) income, net 0 0    
Loss before income taxes 6,734 14,693    
(Benefit) income for income taxes 0 0    
Equity in (loss) income of subsidiaries (14,588) 28,482    
Net loss (7,854) 43,175    
Comprehensive (loss) income (2,747) $ 75,731    
Current assets:        
Cash and cash equivalents 0   0  
Accounts receivable, net (8,408)   (17,795)  
Inventories (67,251)   (65,216)  
Other current assets 0   0  
Assets held for sale 0   0  
Total current assets (75,659)   (83,011)  
Property, plant and equipment, net (4,294)   (4,409)  
Other assets:        
Other intangible assets, net 0   0  
Goodwill 0   0  
Deferred income taxes 0   0  
Other non-current assets (8,849,551)   (7,136,321)  
Total other assets (8,849,551)   (7,136,321)  
Total assets (8,929,504)   (7,223,741)  
Current liabilities:        
Short-term borrowings, including current portion of long-term obligations 0   0  
Trade accounts payable 0   0  
Employee compensation and benefits 0   0  
Advance payments and progress billings (12,267)   (480)  
Accrued warranties 0   0  
Other accrued liabilities (5,576)   (5,544)  
Total current liabilities (17,843)   (6,024)  
Long-term obligations 0   0  
Other liabilities:        
Liabilities for postretirement benefits 0   0  
Accrued pension costs 0   0  
Other non-current liabilities 0   0  
Total other liabilities 0   0  
Shareholders’ equity (8,911,661)   (7,217,717)  
Total liabilities and shareholders’ equity $ (8,929,504)   $ (7,223,741)